Transvascular
Menlo Park, California, United States
About Transvascular
Transvascular develops products for the treatment of coronary and peripheral vascular disease and congestive heart failure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $10.8M
- Funding stage: M&A
- Last round: Series D (Jul 2002)
Industries & Categories
Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/transvascular-2452646 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.